Gene · 84061
MAGT1: magnesium transporter 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MAGT1: magnesium transporter 1. Genes, record 84061. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/84061
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9H0U3 | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1 | 335 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents150
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 223 | Q9H0U3 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 18532 | Q9H0U3 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 8272 | Q9H0U3 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 2519 | Q9H0U3 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6968 | Q9H0U3 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2519 | Q9H0U3 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6968 | Q9H0U3 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 18532 | Q9H0U3 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 31144 | Q9H0U3 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 8272 | Q9H0U3 | Espacenet |
1 to 10 of 150
See all 150 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,218
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MAGT1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 13 | 2025 |
| ZIAAI000913 | Epstein-Barr Virus Associated Disorders | 11 | 2025 |
| ZIAAI001059 | Defining New Human Immunodeficiency and Immunodysregulation Disorders | 11 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 9 | 2025 |
| R01DK099551 | New Congenital Disorders of Glycosylation: Therapy and Models | 7 | 2025 |
| R35CA197589 | Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| ZIAAI000646 | Transgenic Animal Models Of Human Immune Defects | 5 | 2025 |
| ZIAAI000647 | Genes And Gene Products As Immunoadjuvants | 5 | 2025 |
1 to 10 of 1,218Source NIH's project files
See all 1,218 nih grantsPapers1,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spectrum of Primary Hemophagocytic Lymphohistiocytosis-Associated Gene Mutations in Chinese Patients. | MedComm (2020) | 2026 | 42688879 | PubTator, text mining | PubMed |
| The lithium-magnesium-zinc axis under stress: regulation of N-glycosylation-linked proteostasis and Alzheimer's disease. | Inflammopharmacology | 2026 | 42680959 | PubTator, text mining | PubMed |
| Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan. | J Natl Cancer Inst | 2026 | 42569934 | PubTator, text mining | PubMed |
| Biomarkers for assessing magnesium status. | Adv Clin Chem | 2026 | 42336500 | PubTator, text mining | PubMed |
| The SMAC-mimetic xevinapant differentially enhances cisplatin and immune checkpoint blockade efficacy in high-risk HPV-positive tumors. | Transl Oncol | 2026 | 42235210 | PubTator, text mining | PubMed |
| Integrative Genomic Analysis Identifies MAGT1 as a Key Regulator of Proliferation and Poor Prognosis in Breast Cancer. | Hum Mutat | 2026 | 42006149 | PubTator, text mining | PubMed |
| Modifier-Sensitive Phenotypic Divergence in XMEN Disease (MAGT1 Deficiency): Neurodegenerative and Immuno-Hematologic Trajectories. | J Clin Med | 2026 | 41899319 | PubTator, text mining | PubMed |
| Risk of Functional Disorders and/or Thyroid Autoimmunity and Its Association with 25OH Vitamin D and Magnesium Levels: A Population-Based Case-Control Study. | Med Sci (Basel) | 2026 | 41892858 | PubTator, text mining | PubMed |
| Second allogeneic stem cell transplantation for XMEN disease. | BMJ Case Rep | 2026 | 41871900 | PubTator, text mining | PubMed |
| Case Report: Novel MAGT1 pathogenic variant with significant atopy, hypogammaglobulinemia and viral skin infections. | Front Immunol | 2026 | 41777878 | PubTator, text mining | PubMed |
1 to 10 of 1,892
See all 1,892 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/84061
GET https://conductscience.org/api/genes/v1/84061/patents?page=2